Log in

Relevant bibliographies by topics / Malignant diseases in children / Journal articles

To see the other types of publications on this topic, follow the link: Malignant diseases in children.

Journal articles on the topic 'Malignant diseases in children'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Malignant diseases in children.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Gebauer, Ervin. "Malignant diseases in children: Challenges and perspectives." Medical review 56, no. 9-10 (2003): 399–401. http://dx.doi.org/10.2298/mpns0310399g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dahllöf, Göran. "Craniofacial growth in children treated for malignant diseases." Acta Odontologica Scandinavica 56, no. 6 (1998): 378–82. http://dx.doi.org/10.1080/000163598428365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Purtilo, David T. "Malignant lymphomas in children with primary immunodeficiency diseases." Clinical Transplantation 6, no. 3pt2 (1992): 223–26. http://dx.doi.org/10.1111/j.1399-0012.1992.tb00625.x.

Full text

Abstract:

X‐linked lymphoproliferative disease (XLP) is characterized by exquisite vulnerability to Epstein‐Barr virus (EBV). It serves as a model for studying EBV‐induced non‐Hodgkin's lymphoma in immunodeficient patients. EBV was etiologically linked with African Burkitt lymphoma (BL), nasopharyngeal carcinoma (NPC), and infectious mononucleosis (IM) prior to the discovery of XLP in 1975. Studies of males affected with XLP have shown that EBV is responsible for diverse diseases well beyond the three diseases discovered during the initial decade (1964‐1974) following isolation of the virus. The study o

APA, Harvard, Vancouver, ISO, and other styles

4

Mišak, Zrinjka, and Sara Sila. "Nutritional interventions in children treated for malignant diseases." Paediatria Croatica 68, no. 2 (2024): 89–95. http://dx.doi.org/10.13112/pc.2024.13.

Full text

Abstract:

Introduction: Nutrition is of great importance in the treatment of malignant diseases because the nutritional status affects the outcome of the disease itself, the tolerance of chemotherapy and the overall survival and quality of life. This is especially important in childhood when, in addition to the treatment of the underlying disease, it is necessary to ensure the normal growth and development of the child. Objective: The aim of this paper was, based on a review of the literature, to point out the importance and show the basics of nutritional assessment and monitoring, as well as nutritiona

APA, Harvard, Vancouver, ISO, and other styles

5

Muenscher, A., T. Diegel, M. Jaehne, J. Ussmüller, S. Koops, and M. Sanchez-Hanke. "Benign and malignant salivary gland diseases in children." Auris Nasus Larynx 36, no. 3 (2009): 326–31. http://dx.doi.org/10.1016/j.anl.2008.07.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sobirova, Nozila. "RISK AND TREATMENT OF SYMPTOMS OF TUMOR DISEASES IN CHILDREN." MODERN SCIENCE AND RESEARCH 3, no. 1 (2024): 1142–47. https://doi.org/10.5281/zenodo.10604284.

Full text

Abstract:

<em>Brain tumors make up to 20% of malignant tumor diseases in children. These tumors differ from each other in their structure and characteristics. In children, medullablastomas (tumors that develop independently), as well as astrocytomas (malignant tumors of the central nervous system), glioblastomas that arise in the spinal cord, and ependymoma tumors that develop in the internal spaces of the brain are found in children.</em>

APA, Harvard, Vancouver, ISO, and other styles

7

Bilić, Ernest, and Matej Jelic. "Mjesto zbrinjavanja djetetasa solidnim malignim tumorom u Hrvatskoj." Paediatria Croatica 68, no. 2 (2024): 65–69. http://dx.doi.org/10.13112/pc.2024.9.

Full text

Abstract:

Malignant diseases in the paediatric population are rare and account for only 0.5% of all newly diagnosed malignant diseases. In Croatia, 105 to 125 children are diagnosed with malignant diseases every year. As in most countries of the European Union, they are the second most common cause of death in this age group, after accidents. Treatment outcomes for children with malignant diseases in Croatia are comparable to those in other countries of the European Union. Due to the small number of patients, only slightly more than one hundred new patients per year, it would be necessary to centralize

APA, Harvard, Vancouver, ISO, and other styles

8

Heneghan, Chelsea, Elana Smilow, Yvette Tanhehco, et al. "Safety of hematopoietic cell infusion in children with malignant and non-malignant diseases." Pediatric Transplantation 21, no. 7 (2017): e13038. http://dx.doi.org/10.1111/petr.13038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Deordieva, E. A. "VACCINATION OF CHILDREN WITH MALIGNANT DISEASES: THE URGENCY OF THE PROBLEM." Pediatria. Journal named after G.N. Speransky 100, no. 3 (2021): 130–34. http://dx.doi.org/10.24110/0031-403x-2021-100-3-130-134.

Full text

Abstract:

Currently, the number of cases of malignant diseases in children is increasing, but the number of children who have recovered is also increasing. In the past few years, the number of deaths has decreased thanks to the latest technologies for treating cancer patients, but there are still a number of problems in the lives of small patients after treatment. One of the important problems is the lack of continuation of the mandatory vaccination of children who have undergone a malignant disease, according to age and in accordance with the national calendar, despite the availability of clinical guid

APA, Harvard, Vancouver, ISO, and other styles

10

Trifonova, G. "Algorithm for dental treatment in children with malignant diseases." Varna Medical Forum 10, no. 2 (2021): 237. http://dx.doi.org/10.14748/vmf.v10i2.7908.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Adrienne, Horváth, and Papp Zsuzsanna Erzsébet. "Chemotherapy induced liver toxicity in children with malignant diseases." Bulletin of Medical Sciences 91, no. 1 (2018): 37–41. http://dx.doi.org/10.2478/orvtudert-2018-0002.

Full text

Abstract:

Abstract A broad spectrum of chemotherapy is being used in the therapy of childhood cancers, which may induce liver injury, impairing quality of life and efficacy of the treatment. History of, especially viral, liver diseases may increase toxicity. The aim of the paper is to assess the incidence, type and grade, predisposing factors and treatment options of drug-induced liver injury in children with malignant diseases under cytostatic therapy at the Hemato-Oncology Department of the Pediatric Clinic 2 from Targu-Mures, over a time period spanning from 2012 to 2017. The results of the study may

APA, Harvard, Vancouver, ISO, and other styles

12

Nath, Christa E., Andrew J. McLachlan, Peter J. Shaw, John C. Coakley, and John W. Earl. "Amphotericin B Dose Optimization in Children with Malignant Diseases." Chemotherapy 53, no. 2 (2007): 142–47. http://dx.doi.org/10.1159/000100013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kovacs, Gabor T., Olga Barany, Barbara Schlick, et al. "Late Immune Recovery in Children Treated for Malignant Diseases." Pathology & Oncology Research 14, no. 4 (2008): 391–97. http://dx.doi.org/10.1007/s12253-008-9073-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

K. Mahdi, Nadham, Maysloon A. Al-Sadoon, and Genan K. Hassan. "CRYPTOSPORIDIOSIS AND IMMUNOLOGICAL STATUS IN CHILDREN WITH MALIGNANT DISEASES." Medical Journal of Basrah University 25, no. 1 (2007): 1–6. http://dx.doi.org/10.33762/mjbu.2007.48779.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Slijepčević, Jelena. "Needs and Difficulties of Parents with Children Suffering from Malignant Diseases." Croatian nursing journal 6, no. 1 (2022): 83–93. http://dx.doi.org/10.24141/2/6/1/7.

Full text

Abstract:

Malignant diseases are one of the leading causes of death in children in developed countries, although constant progress in therapy is continuously decreasing mortality. The diagnosis of malignant disease is a significant stressor in the life of a child and its family, significantly affecting the quality of life for the entire family. it constitutes the prototype of a stressful situation and a disease with a potentially devastating effect on the child and its family. This paper discusses 50 professional and scientific papers published between 1993 and 2022 that explore the needs and difficulti

APA, Harvard, Vancouver, ISO, and other styles

16

White, Ann K., and Richard J. H. Smith. "Thyroid Nodules in Children." Otolaryngology–Head and Neck Surgery 95, no. 1 (1986): 70–75. http://dx.doi.org/10.1177/019459988609500114.

Full text

Abstract:

Thyroid nodules are infrequently encountered in children. During the era of low-dose therapeutic irradiation, the incidence of malignancy in these lesions was 40% to 70%. Recent studies suggest that this incidence is declining, resulting in a concomitant relative increase in the proportion of benign nodular conditions. There is also a heightened awareness that secondary thyroid neoplasms may occur in children surviving primary malignant diseases. Records of 38 children treated surgically at Texas Children's Hospital between 1972 and 1984 have been reviewed to determine the incidence of benign

APA, Harvard, Vancouver, ISO, and other styles

17

Albert, Michael H., Johanna Tischer, Daniel Stachel, et al. "Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Children with Malignant and Non-Malignant Diseases." Blood 124, no. 21 (2014): 5842. http://dx.doi.org/10.1182/blood.v124.21.5842.5842.

Full text

Abstract:

Abstract Background: HLA haploidentical stem cell transplantation with T-replete grafts and post-transplant immunosuppression with high-dose cyclophosphamide after reduced intensity conditioning has evolved into an increasingly accepted method of alternative donor transplantations in adults. Reported transplantation related mortality, GVHD and relapse rates are at least comparable to those of HLA matched donor transplantations. Purpose: To assess the feasibility of this approach in children as a first or second allogeneic transplantation after myeloablative or reduced toxicity conditioning. Pa

APA, Harvard, Vancouver, ISO, and other styles

18

Menzinger, Sébastien, and Sylvie Fraitag. "Pseudomalignancies in Children: Histological Clues, and Pitfalls to Be Avoided." Dermatopathology 8, no. 3 (2021): 376–89. http://dx.doi.org/10.3390/dermatopathology8030042.

Full text

Abstract:

The term “pseudomalignancy” covers a large, heterogenous group of diseases characterized by a benign cellular proliferation, hyperplasia, or infiltrate that resembles a true malignancy clinically or histologically. Here, we (i) provide a non-exhaustive review of several inflammatory skin diseases and benign skin proliferations that can mimic a malignant neoplasm in children, (ii) give pathologists some helpful clues to guide their diagnosis, and (iii) highlight pitfalls to be avoided. The observation of clinical–pathological correlations is often important in this situation and can sometimes b

APA, Harvard, Vancouver, ISO, and other styles

19

Ozsevik, Sevinc N., Gulnar Sensoy, Arzu Karli, et al. "Invasive Fungal Infections in Children With Hematologic and Malignant Diseases." Journal of Pediatric Hematology/Oncology 37, no. 2 (2015): e69-e72. http://dx.doi.org/10.1097/mph.0000000000000225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Siden, Harold. "Pediatric Palliative Care for Children with Progressive Non-Malignant Diseases." Children 5, no. 2 (2018): 28. http://dx.doi.org/10.3390/children5020028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

WADA, Ikuo, Takeo TAKEDA, Michiko SATO, et al. "Pharmacokinetics of Granisetron in Adults and Children with Malignant Diseases." Biological & Pharmaceutical Bulletin 24, no. 4 (2001): 432–35. http://dx.doi.org/10.1248/bpb.24.432.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Nath, Christa E., Andrew J. McLachlan, Peter J. Shaw, Robyn Gunning, and John W. Earl. "Population pharmacokinetics of amphotericin B in children with malignant diseases." British Journal of Clinical Pharmacology 52, no. 6 (2001): 671–80. http://dx.doi.org/10.1046/j.0306-5251.2001.01496.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Donma, Orkide, Füsun Atlihan, Mehmet Ali Tas, and M. Metin Donma. "Serum Fructosamine and Lipid Profile in Children with Malignant Diseases." Pediatrics International 32, no. 5 (1990): 540–42. http://dx.doi.org/10.1111/j.1442-200x.1990.tb00876.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Habib, OS, and Ali H. Atwan. "One-year survival of children with malignant diseases in Basrah." Medical Journal of Basrah University 35, no. 1 (2017): 1–10. http://dx.doi.org/10.33762/mjbu.2017.125131.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Simic, Dusica, Dragana Bogicevic, Irina Milojevic, Ivana Budic, and Marija Markovic. "Anaesthesia in children with inherited neuromuscular diseases." Srpski arhiv za celokupno lekarstvo 138, no. 11-12 (2010): 768–76. http://dx.doi.org/10.2298/sarh1012768s.

Full text

Abstract:

Children with inherited neuromuscular diseases often require anaesthesia for diagnostic or therapy procedures. These patients have an increased risk of perioperative complications due to the nature of the disease and medications administered during anaesthesia. Many anaesthetics and muscle relaxants can aggravate the underlying disease and trigger life-threatening reactions (cardiorespiratory complications, malignant hyperthermia). Besides, the neuromuscular disorders are associated with atypical and undesirable responses to drugs used during anaesthesia and the perioperative period. The paper

APA, Harvard, Vancouver, ISO, and other styles

26

Morozov, A. K., A. A. Belyaeva, and A. L. Kornachev. "Radiographic Findings for Diagnosis of Primary Tumors 35 and Tumor-Like Diseases of Spine in Children." N.N. Priorov Journal of Traumatology and Orthopedics 3, no. 3 (1996): 35–40. http://dx.doi.org/10.17816/vto101791.

Full text

Abstract:

Retrospective analysis of radiographic semiotics in tumors and tumor-like diseases of spine was performed in 179 children, aged 3-16. Fourteen nosologic forms were revealed, diagnosis was verified morphologically. Eleven patients had malignant tumors (osteogenic sarcoma, Ewings sarcoma, malignant osteoblastoma, chondrosarcoma, malignant neuroblastoma); 67 patients had benign tumors (osteoid-osteoma, osteoblastoma, hemangioma, osteoblastoclastoma, osteochondroma, neurogenic tumors, chondroma); tumor-like diseases were revealed in 101 patients (aneurismal bone cyst, eosinophilic granuloma). The

APA, Harvard, Vancouver, ISO, and other styles

27

McCully, Kilmer S. "Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging." Comprehensive Physiology 6, no. 1 (2016): 471–505. https://doi.org/10.1002/j.2040-4603.2016.tb00682.x.

Full text

Abstract:

ABSTRACTThe importance of homocysteine in vascular function and arteriosclerosis was discovered by demonstration of arteriosclerotic plaques in children with homocystinuria caused by inherited enzymatic deficiencies of cystathionine synthase, methionine synthase, or methylene‐tetrahydrofolate reductase. According to the homocysteine theory of arteriosclerosis, an elevated blood homocysteine level is an important risk factor for atherosclerosis in subjects without these rare enzymatic abnormalities. The homocysteine theory is supported by demonstration of arterial plaques in experimental animal

APA, Harvard, Vancouver, ISO, and other styles

28

Kopecky, Ernest A., Sheila Jacobson, Prashant Joshi, Maria Martin, and Gideon Koren. "Review of a Home-Based Palliative Care Program for Children with Malignant and Non-Malignant Diseases." Journal of Palliative Care 13, no. 4 (1997): 28–33. http://dx.doi.org/10.1177/082585979701300405.

Full text

Abstract:

This retrospective chart review presents the patient characteristics and utilization of the home-based palliative care program at The Hospital for Sick Children in Toronto. A total of 126 children dying from a broad spectrum of diseases was admitted during the period 1986–1994, referred from neurosurgery, genetic/metabolic, neurology, neonatology, nephrology, cardiology, general pediatrics, general surgery, and pulmonology. At the time of review, 15 patients remained alive and 18 had been discharged from the program. Mean age at the time of referral was 4.8 ± 0.51 years and mean age at death w

APA, Harvard, Vancouver, ISO, and other styles

29

Jovanovic, Nada, Dragana Janic, Lidija Dokmanovic, Dejan Skoric, and Jelena Lazic. "Frequency and characteristics of hepatitis B infection in children with malignant diseases." Srpski arhiv za celokupno lekarstvo 133, no. 7-8 (2005): 353–57. http://dx.doi.org/10.2298/sarh0508353j.

Full text

Abstract:

Introduction. Hepatitis B, a complication of blood transfusion or other means of transmission, occurs with variable frequency in children with malignant diseases. Objective. The objective of this study was to determine the frequency of hepatitis B virus infection in children with malignant diseases, to investigate the clinical course of the illness, and to analyze the influence of hepatitis on cytotoxic treatment. Method. The study included children diagnosed and treated for malignant diseases at the University Children's Hospital in Belgrade from 1997 to 2003. HBs Ag was analyzed in all patie

APA, Harvard, Vancouver, ISO, and other styles

30

Morozova, D. S., D. A. Evstratov, and P. A. Zharkov. "Recurrent deep vein thrombosis in children with malignant blood diseases: literature review." Oncohematology 14, no. 2 (2019): 24–28. http://dx.doi.org/10.17650/1818-8346-2019-14-2-24-28.

Full text

Abstract:

Venous thromboembolism is not a rare complication in children with cancer. Despite the advantages of the treatment of venous thromboembolism there is still a probability of venous thromboembolism recurrence. In adult patients with cancer venous thromboembolism recurrence an influence on the lower survival rate. In children with cancer venous thromboembolism recurrence is a rare complication, but it can significantly reduce the quality of life. Risk factors of venous thromboembolism recurrence in children with cancer are not properly investigated.

APA, Harvard, Vancouver, ISO, and other styles

31

Mijatović, Luka, Dragan Rapaić, Danijela Ilić-Stošović, Snežana Ilić, Jasmina Maksić, and Dragan Marinković. "Investigation of motivation for providing support to children with malignant diseases." Materia Medica 31, no. 2 (2015): 1305–13. http://dx.doi.org/10.5937/matmed1502305m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Kondratyeva, E. I., E. V. Loshkova, N. V. Kolesnikova, N. V. Tarasenko, A. V. Trembach, and T. V. Asekretova. "An immunological and genetic characteristic of malignant blood diseases in children." Voprosy gematologii/onkologii i immunopatologii v pediatrii 15, no. 4 (2016): 81–88. http://dx.doi.org/10.20953/1726-1708-2016-4-81-88.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Pasqualotto, Gilberto Comar??, Felipe Ant??nio Copetti, Clarice Franco Meneses, Ad??o Rog??rio Leal Machado, and Algemir Lunardi Brunetto. "Infection by Rhodotorula sp. in Children Receiving Treatment for Malignant Diseases." Journal of Pediatric Hematology/Oncology 27, no. 4 (2005): 232–33. http://dx.doi.org/10.1097/01.mph.0000158970.27196.c5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Şerban, M., M. Bǎtǎneant, S. Arghirescu, and V. Şerban. "Hyperglycemia - a rare metabolic anomaly of malignant lymphoproliferative diseases in children." Diabetes Research and Clinical Practice 50 (September 2000): 117. http://dx.doi.org/10.1016/s0168-8227(00)81856-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Attarbaschi, Andishe, and Georg Mann. "Initial emergencies in children and adolescents with malignant hematologic–oncological diseases." memo - Magazine of European Medical Oncology 9, no. 2 (2016): 96–103. http://dx.doi.org/10.1007/s12254-016-0264-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Entacher, U., O. J�rgenssen, L. Thun-Hohenstein, et al. "Hepatitis B vaccination and immune response in children with malignant diseases." European Journal of Pediatrics 144, no. 2 (1985): 160–63. http://dx.doi.org/10.1007/bf00451904.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kondrateva, Elena I., Elena V. Loshkova, Natalya V. Kolesnikova, Anton V. Trembach, Natalya V. Tarasenko, and Tatyana V. Asekretova. "An immunological and genetic characteristic of malignant blood diseases in children." Pediatric Hematology/Oncology and Immunopathology 15, no. 4 (2016): 81–88. https://doi.org/10.24287/1726-1708-2016-15-4-81-88.

Full text

Abstract:

The article discusses the features and genetic regulation of cytokine lymphoproliferative inflammation on the background of a number of hematological malignancies. A total of 70 children (37 (53%) boys and 33 (47%) female), average age of 7,6 ± 2,59 years) with malignant blood diseases. Patients performed immunologic study cytokine status (IL-1 ß, IL-4, IL-10, TNF-a, IFN-y, receptor antagonist IL-1 (I_-1Ra)), and molecular genetic testing gene polymorphisms - immune response modifiers family interleukin-1 (IL1RN*VNTR gene polymorphism, IL1B (rs1143634)) and tumor necrosis factor (TNFA*G-308A (

APA, Harvard, Vancouver, ISO, and other styles

38

Piastra, Marco, Giuliana Fognani, and Alessia Franceschi. "Pediatric Intensive Care Unit admission criteria for haematooncological patients: a basis for clinical guidelines implementation." Pediatric Reports 3, no. 3 (2011): 13. http://dx.doi.org/10.4081/pr.2011.e13.

Full text

Abstract:

Cancer remains a major death cause in children, though outcomes have considerably improved over the past decades (1-3). Outcomes for children diagnosed with cancer have changed since ’70 from 80% mortality to 80% survival (2); while children with solid tumors 5-year survival has been reported as 67%, cure rates for childhood leukemia now approach 90% [4-5). Moreover, hematopoietic stem cell transplantation (HSCT) indications are still expanding for both malignant and non-malignant diseases.

APA, Harvard, Vancouver, ISO, and other styles

39

Ivaila, Georgieva, and Petrova Guergana. "Parents of children with oncological diseases and the employment market in Bulgaria." Asian Pacific Journal of Nursing and Health Sciences 2, no. 1 (2019): 1–6. https://doi.org/10.5281/zenodo.3831222.

Full text

Abstract:

The problem with the employment of parents of children with oncological diseases is not new and with so many supporting organizations and media influences is expected to be solved, but it is not the case. We asked ourselves are employers familiar with the professional abilities, physical and psychological health of parents of children with malignant diseases? Are there any preferences and programs equally effective for the employers and the employees? The research of the team of the current study draws to the conclusion that currently, the social integration of disadvantaged and vulnerable gro

APA, Harvard, Vancouver, ISO, and other styles

40

BAZARBAYEVA, A. A., R. Z. BORANBAYEVA, L. N. MANZHUOVA, K. S. SHAKHMETOVA, G. K. ABDILOVA, and G. A. NURZHANOVA. "Experience in teaching cancer alertness to primary care doctors in the Republic of Kazakhstan." Oncologia i radiologia Kazakhstana 1, no. 59 (2021): 4–7. http://dx.doi.org/10.52532/2521-6414-2021-1-59-4-7.

Full text

Abstract:

Relevance: Malignant neoplasms (MN) lead the structure of childhood mortality worldwide. At that, most cases are detected at advanced stages. Early diagnostics is required to improve treatment outcomes in children with cancer. The success mainly depends on oncological alertness and knowledge of primary care doctors. The study aimed to analyze the results of training primary care doctors in early diagnostics of oncological and hematological diseases in children using MN staging. Results: The paper shares the experience of teaching primary care doctors on early diagnostics of oncological and hem

APA, Harvard, Vancouver, ISO, and other styles

41

Flinsenberg, T. W. H., I. H. Bartelink, T. F. T. T. Ververs, M. Bierings, and J. J. Boelens. "Busulfan+Fludarabine, An Effective And Low Toxic Regimen In Children With Malignant And Non-Malignant Diseases." Biology of Blood and Marrow Transplantation 16, no. 2 (2010): S244. http://dx.doi.org/10.1016/j.bbmt.2009.12.271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

CHEREZOVA, I. N., N. KH GABITOVA та I. V. OSIPOVA. "Нepatoblastoma in young children". Practical medicine 21, № 1 (2023): 63–68. http://dx.doi.org/10.32000/2072-1757-2023-1-63-68.

Full text

Abstract:

Hepatoblastoma is a common primary malignant tumor in children aged 0 to 4 years. In the structure of liver neoplasms, the pathology occupies 80% and has been steadily growing over the past 30 years with an annual increase of 4–5%. Risk factors for the development of hepatoblastoma include an increase in the survival rate of deeply premature babies, oxidative tissue damage associated with intensive therapy of low birth weight premature babies, and IVF. The disease has no specific complaints and characteristic clinical manifestations. The initial manifestations of hepatoblastoma are often hidde

APA, Harvard, Vancouver, ISO, and other styles

43

Ashraf, Tanveer, Shoaib Ahmed, and Saman Tanveer. "FACTORS ASSOCIATED WITH DELAY IN CANCER DIAGNOSIS AND TREATMENT IN CHILDREN, A STUDY FROM NORTHERN PAKISTAN." Professional Medical Journal 26, no. 07 (2019): 1156–61. http://dx.doi.org/10.29309/tpmj/2019.26.07.3790.

Full text

Abstract:

Objectives: This study explores various factors responsible for delay in management of Pakistani children having malignant diseases. Study Design: Cross-sectional, observational study. Setting: Pediatric Oncology Unit of Combined Military Hospital Rawalpindi. Period: 1st March 2017 to 31st August 2017. Material and Methods: A total of 147 children, up to 15 years of age, being managed for malignant diseases were enrolled. Data was collected by reviewing the medical record and face-to-face interviews of the parents. Time lag from onset of symptoms to start of treatment was divided in three cate

APA, Harvard, Vancouver, ISO, and other styles

44

MOURA, C. "Malignant melanoma in children and adolescents: A clinical review." Journal of the European Academy of Dermatology and Venereology 11 (September 1998): S307—S308. http://dx.doi.org/10.1016/s0926-9959(98)95761-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Nikitović, Marina, and Dragana Stanić. "Pediatric Radiotherapy Department: Recommendations for optimal infrastructure and personnel." Medicinska istrazivanja 52, no. 3 (2018): 20–24. http://dx.doi.org/10.5937/medist1801020n.

Full text

Abstract:

In multidisciplinary treatment of malignant diseases in pediatric population, radiotherapy with or without surgery, represents the basic modality of local treatment. Although the basic principles of radiotherapy in children are the same as in adults, it has its own specificity because it is applied to an organism in the phase of growth and development. Also, pediatric tumors differ from tumors in adults, so pediatric radiation oncologist has to have knowledge of pediatric oncology. Treatment of children with malignant diseases requires coordinated work of a multidisciplinary team: radiation on

APA, Harvard, Vancouver, ISO, and other styles

46

SHEIKH, MUHAMMAD SALEEM, MASOOD AKHTAR, and MUHAMMAD AMIN SHEIKH. "SUPERFICIAL CERVICAL SWELLING IN CHILDREN." Professional Medical Journal 17, no. 01 (2011): 151–55. http://dx.doi.org/10.29309/tpmj/2010.17.01.2184.

Full text

Abstract:

Fine needle aspiration cytology (FNAC) is commonly used first line diagnostic test for palpable cervical swelling by ENT and Head & Neck surgeon. Objective: To analyze the diagnostic importance of FNAC by knowing its sensitivity and specificity in children having palpable cervical swelling. Design: Prospective study. Setting: Department of ENT and Head Neck Surgery QAMC, Bahawalpur. Period: July 2006 to June 2007. Material And Methods: 82 cases of superficial cervical swelling with ages between 5 and 12 years were selected. Most of them were of poor socioeconomic class. All underwent FNAC

APA, Harvard, Vancouver, ISO, and other styles

47

Gonzalez, M., A. Perez, M. Ramirez, J. Sevilla, L. Madero, and M. A. Diaz. "162: Fludarabine-based reduced-intensity conditioning for allogeneic transplantation in children with malignant and non-malignant diseases." Biology of Blood and Marrow Transplantation 13, no. 2 (2007): 61. http://dx.doi.org/10.1016/j.bbmt.2006.12.166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Dobanovacki, Dusanka, Radoica Jokic, Bozica Vujosevic, and Andjelka Slavkovic. "Development of pediatric oncology." Archive of Oncology 18, no. 4 (2010): 132–35. http://dx.doi.org/10.2298/aoo1004132d.

Full text

Abstract:

The first publication about surgical treatment of tumors in children in medical literature dates from the beginning of the 19th century. Operations were a method of choice to treat. New development in science such as microscopy research, anesthesia, antisepsis, X-ray, and radium therapy has changed the approach to malignant diseases. The remarkable achievements in survival of oncology patients today are the results of a multimodal, multi-institutional, and multidisciplinary collaboration. Pediatric oncology differs from the oncology for adult patients in the type, generic considerations, diagn

APA, Harvard, Vancouver, ISO, and other styles

49

Miyajima, Yuji, Shin-ichiro Numata, Isao Katayama, and Keizo Horibe. "Prevention of Chemotherapy-Induced Emesis with Granisetron in Children with Malignant Diseases." Journal of Pediatric Hematology/Oncology 16, no. 3 (1994): 236–41. http://dx.doi.org/10.1097/00043426-199408000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

LI, Chi-Kong, Vincent Lee, Ki-Wai Chik, Ming-Kong Shing, and Patrick MP Yuen. "Haematopoietic Stem Cell Transplantation (HSCT) for Non-Malignant Haematological Diseases in Children." Journal of Pediatric Hematology/Oncology 27, no. 9 (2005): 465. http://dx.doi.org/10.1097/01.mph.0000188515.15985.e7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!